The inhibition of BRAF and MEK leads to up-regulation of melanoma differentiation antigens (MDA), such as MART-1, gp-100 and tyrosinase, [256] and MHC expression [257] along with decreased immunosuppressive cytokines secretion [246]. The gene discussed is TYR; the disease is melanoma.